Libido and sexual desire
Changes in sexual desire during perimenopause are extremely common, rarely talked about, and almost never explained. This is not about your relationship, your partner, or who you are. Part of it is biology — and part of it is things no one ever taught you. Almost all of it is treatable.
Here's what's actually happening
Low libido affects somewhere between 44% and 50% of women during perimenopause and menopause — and the number climbs significantly as the transition progresses. By the early fifties, the majority of women are experiencing some degree of sexual dysfunction. Most never mention it to a doctor because they assume it's just part of getting older, or they feel embarrassed, or they've already been told nothing can be done. All of that is worth pushing back on.
Several things are happening at once. Estrogen is the one most people know about, but its effect on desire is more indirect than people realize. Estrogen keeps vaginal tissue healthy, supports lubrication, and helps prevent pain during sex. When estrogen drops, sex can become uncomfortable or painful — and it's hard to want something that hurts. Estrogen also helps release dopamine, the brain chemical most directly associated with desire and motivation. Less estrogen means less of that chemical push toward wanting.
Testosterone is the hormone most directly linked to desire — and women make it too, in smaller amounts. Testosterone levels decline gradually with age, and lower levels are independently associated with reduced sexual desire, arousal, and responsiveness. This is often the missing piece for women whose estrogen is treated but who still feel like something is off in terms of drive or interest.
Everything else going on in perimenopause compounds the picture. Poor sleep leaves you too tired. Mood changes make intimacy feel harder to access emotionally. Hot flashes and night sweats create physical discomfort at the times you might otherwise be close. The body and the brain are both working against desire, and blaming yourself or your relationship for that is deeply unfair.
In perimenopause vs. menopause
In perimenopause, changes in desire often fluctuate. Some cycles or weeks may feel more normal than others. Vaginal dryness and discomfort tend to increase as estrogen becomes more erratic — and discomfort during sex has one of the strongest relationships with declining desire of any symptom in the research.
In menopause and beyond, without treatment, the vaginal tissue changes can become more significant over time. Tissue that is thinner and less well-supplied with blood becomes more fragile and more uncomfortable. Desire that was variable in perimenopause can become more consistently absent. These changes are progressive but very treatable, and earlier treatment generally produces better outcomes.
What this means for your care
Estrogen therapy — particularly the patch or gel form rather than a pill — is well supported for improving lubrication, reducing pain, and improving overall sexual satisfaction. A pill form of estrogen actually raises a protein that binds testosterone and makes it less available to your body, which can make desire worse. Transdermal estrogen avoids that problem entirely.
For desire and drive specifically, testosterone therapy has a strong evidence base. An international consensus of leading menopause researchers concluded that transdermal testosterone at appropriate doses increases satisfying sexual experiences, improves desire and arousal, and reduces sexual distress. Both the American College of Obstetricians and Gynecologists and the Endocrine Society support its use for women with low desire. We use FDA-approved testosterone gel at female-appropriate doses — not compounded preparations, which have unreliable absorption.
If you want the full picture of what testosterone does — the timeline, what to expect, and what it won't reach — see Testosterone: The In-Depth Guide. The rest of this page covers the parts of desire that hormones don't reach, because for many women those matter just as much.
There are two kinds of desire — and both are normal
Most conversations about women's libido start with an assumption that doesn't survive close examination: that healthy desire looks like spontaneous, out-of-nowhere wanting. That's the version movies show and marketing implies, and it's the version most women quietly compare themselves against. It doesn't describe most women — including women whose sex lives are deeply satisfying.
There's a useful distinction here. Spontaneous desire arises on its own, without a trigger. Responsive desire arises in response to context, intimacy, or arousal — after something starts rather than before. Both are normal. Both can be deeply satisfying. The mix shifts across life: younger women report more spontaneous desire on average, and through perimenopause and beyond, responsive desire becomes the more common pattern — for everyone, not only women whose hormones have changed.
This matters because women often arrive having internalized the spontaneous-desire model as the standard, and describe themselves as broken when they don't feel it. They're not broken. The real question isn't why don't I want it out of nowhere — it's whether responsive desire is available: whether you can get aroused once something begins, whether sex feels worth doing once you're in it, whether pleasure lands the way it used to.
What we remember as spontaneous desire often wasn't
Here's a reframe worth sitting with: a lot of what you may remember as spontaneous desire from earlier in your life probably wasn't spontaneous at all. It was responsive desire plus anticipation, happening so close together that it felt like a single thing.
Early in a relationship, anticipation is constant. The texts. The planning. Replaying what happened, imagining what's next. The buildup runs in the background continuously, so by the time you're together your body is already primed — and the wanting feels spontaneous because the anticipatory work has been happening on its own. Years into a long partnership, anticipation no longer runs on its own. The relationship is comfortable, the schedules are full, and the buildup has to be created on purpose — and most of us were never taught how.
The things that make a long relationship safe and stable (familiarity, predictability, closeness) are different from the things that generate desire (anticipation, distance, novelty). Long-term couples often accidentally maximize the first set and extinguish the second, then conclude something is wrong with the relationship or with themselves. If what's changed for you is the loss of that constant anticipatory hum, that's not a hormone deficiency — it's a normal feature of long partnership, and it's workable. It's just a different kind of work than a prescription.
The orgasm gap — and why it isn't biology
Most women in their 40s, 50s, and 60s never had real sex education. Neither did most men. We were taught warnings — pregnancy, STIs, "wait until you're married" — and not much else. A lot of what people now think sex should look like was learned from pornography, which is performance, not data. The expectations that follow rarely match how women's bodies actually work, and that mismatch causes a lot of unnecessary suffering on every side.
The data make the gap concrete:
- Median time to orgasm during partnered sex: about 5–6 minutes for men, about 13 minutes for women.
- In heterosexual encounters, women orgasm about 65% of the time; men about 95%. Among women with women, the rate is about 86%.
- When clitoral stimulation is consistently part of what's happening, women's orgasm rate roughly doubles.
That gap isn't biological. Typical sex was organized around what works for men's bodies, and the rest is an information and skill gap most of us inherited. Once you have accurate information about what works for your body, the gap closes faster than most women expect.
This matters for your care because some of what feels like a hormonal problem turns out to be an information problem. A woman whose desire has flattened in midlife may also have been operating, her whole life, on incomplete information about her own body. Hormones do real work on the hormonal layer. The information layer is separate, completely treatable, and not pharmacology.
When it isn't the hormones
Researchers describe sexual response as a system of accelerators and brakes. Accelerators turn the system on: attraction, anticipation, the right kind of touch, feeling safe, feeling wanted. Brakes turn it off: stress, exhaustion, body-image distress, resentment, pain, distraction, and certain medications. Hormones work on the accelerators — they can make them more sensitive and easier to engage. They don't release brakes. If your brakes are heavily engaged, pressing harder on the accelerator doesn't make the system go. The brake has to come off first, or alongside.
The brakes that hormones won't override, and what each actually needs:
- Pain with sex. If sex hurts, your brain protects you — that's a survival system doing its job, not a failing. Pain in midlife is usually a vaginal tissue problem, treated with vaginal estrogen. If sex has been painful before, the protective response can linger even after the tissue heals, and that's unwound slowly — sometimes pelvic floor physical therapy, sometimes sex therapy, often both.
- SSRIs and SNRIs. These antidepressants flatten libido and dull arousal in a substantial fraction of women who take them, and no hormone overrides that. It doesn't mean stopping a medication that's working — but it's a real conversation, and sometimes there are alternatives with less sexual impact.
- Sleep debt and chronic stress. No medication overrides exhaustion. Desire is downstream of having enough in your nervous system to want anything at all. This is the floor underneath which other interventions don't perform.
- Relationship dynamics and the anticipation layer. The novelty, communication, and erotic conditions of a long partnership — hormones support the capacity for desire, but they don't recreate these.
- The information gap. Not having been taught what arousal looks like or what works for your body — learnable, but not from a prescription.
If your desire stays low after hormones are optimized, that is not a treatment failure. It's information — it tells us which brake is engaged, so we can go to work on the right one.
What helps, beyond hormones
For the layers hormones don't reach, these are the resources we trust. Each is evidence-based, and each does something specific. None of this is your fault, and none of it is something you were ever taught.
Resources we recommend
Laurie Bonura, LMSW, MEd
A sex therapist in the New Orleans area we work with directly — for the layered work, when desire is tangled with pain, trauma history, body image, or relationship dynamics. In-person or video.
Ferly
An app for building responsive desire as a skill — daily guided exercises for when your body feels back online but the wanting hasn't caught up.
Esther Perel — Bringing Back Desire
A self-paced course for the long-relationship "we love each other but the spark is gone" pattern — the anticipation, distance, and mystery that keep desire alive in a committed partnership.
OMGYES
A research-based platform for the technique and orgasm gap — concrete, evidence-based answers about what actually works.
See the full descriptions, contact details, and links on our Sexual Health Resources page.
The sources behind this page
- Davis SR. Sexual Dysfunction in Women. N Engl J Med. 2024.
- Basson R. The Female Sexual Response: A Different Model. J Sex Marital Ther. 2000.
- Bancroft J, Graham CA, Janssen E, Sanders SA. The Dual Control Model: Current Status and Future Directions. J Sex Res. 2009.
- Frederick DA, St John HK, Garcia JR, Lloyd EA. Differences in Orgasm Frequency Among Gay, Lesbian, Bisexual, and Heterosexual Men and Women in a U.S. National Sample. Arch Sex Behav. 2018.
- Lara LA, Cartagena-Ramos D, Figueiredo JB, et al. Hormone Therapy for Sexual Function in Perimenopausal and Postmenopausal Women. Cochrane Database Syst Rev. 2023.
- Cagnacci A, Venier M, Xholli A, et al. Female Sexuality and Vaginal Health Across the Menopausal Age. Menopause. 2020.
- Taylor HS, Tal A, Pal L, et al. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: KEEPS Ancillary Study. JAMA Intern Med. 2017.
- Davis SR, Baber R, Panay N, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab. 2019.
- Islam RM, Bond M, Ghalebeigi A, et al. Prevalence and Severity of Symptoms Across the Menopause Transition: AMY Study. Lancet Diabetes Endocrinol. 2025.
- Savukoski SM, Pinola PA, Pesonen PRO, et al. Climacteric Status Is Associated With Sexual Dysfunction at the Age of 46 Years. Menopause. 2022.
- Meziou N, Scholfield C, Taylor CA, Armstrong HL. Hormone Therapy for Sexual Function: A Systematic Review and Meta-Analysis Update. Menopause. 2023.